| NDC Code | 49281-720-10 |
|---|
| Package Description | 10 SYRINGE in 1 CARTON (49281-720-10) > .5 mL in 1 SYRINGE (49281-720-88) |
|---|
| Product NDC | 49281-720 |
|---|
| Product Type Name | VACCINE |
|---|
| Proprietary Name | Flublok Quadrivalent Northern Hemisphere |
|---|
| Non-Proprietary Name | Influenza A Virus A/hawaii/70/2019 (h1n1) Recombinant Hemagglutinin Antigen, Influenza A Virus A/minnesota/41/2019 (h3n2) Recombinant Hemagglutinin Antigen, Influenza B Virus B/washington/02/2019 Recombinant Hemagglutinin Antigen, And Influenza B Virus B/phuket/3073/2013 Recombinant Hemagglutinin Antigen |
|---|
| Dosage Form | INJECTION |
|---|
| Usage | INTRAMUSCULAR |
|---|
| Start Marketing Date | 20200702 |
|---|
| End Marketing Date | 20210630 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA125285 |
|---|
| Manufacturer | Sanofi Pasteur Inc. |
|---|
| Substance Name | INFLUENZA A VIRUS A/HAWAII/70/2019 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA A VIRUS A/MINNESOTA/41/2019 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/WASHINGTON/02/2019 RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/PHUKET/3073/2013 RECOMBINANT HEMAGGLUTININ ANTIGEN |
|---|
| Strength | 45; 45; 45; 45 |
|---|
| Strength Unit | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
|---|